20 May 2013
Keywords: oxis, ergo, boosted, german, study, california, usa-based
Article | 16 July 2007
California, USA-based biopharmaceutical firm Oxis International says that a research group led by Dirk Grundemann at the University of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 July 2007
17 May 2013
© 2013 thepharmaletter.com